retatrutide compounding Retatrutide: The Complete Guide for Pharmacies in 2025 What To Know About Buying

Diabetes leads to a significantly accelerated incidence of various related macrovascular complications, including peripheral vascular disease and cardiovascular disease (the most common cause of mortality in diabetes), as well as microvascular complications such as kidney disease and retinopathy

PlexusDx provides access to compounded semaglutide injections and other GLP-1 options designed to fit your timeline, budget, and genetic profile

An editorial review of Agile Health business model, compounded-pharmacy pathway, patient reports, and fair-balance safety

Efficacy and Safety of GLP-3, a Novel GLP-1, GIP, and Glucagon Receptor Agonist for Obesity Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Abdrabou Abouelmagd A

A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices.

The GLP-1 Hydration Products Market worth USD 1.2 billion in 2026 is growing at a CAGR of 17.0% to reach USD 5.8 billion by 2036